BBTX insider trading news
Large insider purchases and sales at BBTX, from SEC Form 4 filings.
-
RA Capital Management, L.P., a director at Bambusa Therapeutics, Inc., buys $46.6M of stock
An open-market purchase between Oct 30 and Nov 2, reported to the SEC on Nov 3.
-
Three insiders buy Bambusa Therapeutics, Inc. shares, $58.6M in total
Open-market purchases on Nov 2, led by RA Capital Management, L.P. (director).
-
Bambusa Therapeutics, Inc. director Helmut Wolfgang Jeggle adds $6M of BBTX stock
After the purchase, the filing lists 9,264,301 shares held.
-
Bambusa Therapeutics, Inc. 10% holder Salvia Investment GmbH purchases $6M in BBTX shares
After the purchase, the filing lists 9,264,301 shares held.